TAVR (TAVI)
This special “Great Debate” article discusses whether surgical aortic valve replacement (SAVR) should remain the first choice for aortic stenosis in patients with a life expectancy beyond five years. The pro side emphasizes the scarcity...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Aamir Amin, a cardiothoracic surgery resident at Manchester University NHS Foundation Trust, UK, about humanoid robots and artificial...
This session features leading surgeons discussing the tricuspid valve at the Transcatheter Heart Valves Greece (THVGreece) 2026 conference. Moderators Vassilis Voudris, Director of the Cardiology/Interventional Cardiology Division, Onassis Cardiac Surgery...
In this episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Filip Casselman, Staff Surgeon and Co-Director of the Cardiovascular Center at OLV Clinic (AZORG), Aalst, Belgium, about...
This video completes a day of excellent presentations by leading surgeons exploring advanced minimally invasive techniques including congenital ventricular septal defect (VSD) surgery, endoscopic transcatheter aortic valve replacement (TAVR) explantation,...
On Wednesday March 13, the ACC Quality Summit announced in New Orleans that beginning in mid-2019, hospitals performing transcatheter valve repair and replacement will be able to apply for the...
Patient Care and General Interest The American Heart Association has released a scientific statement summarizing emerging knowledge about sensitization after heart transplant. The National Health Service England in the UK...
Kofler and colleagues evaluated prospectively-measured psoas muscle area in more than 1,000 patients who underwent transcatheter aortic valve replacement at two centers. Indexed psoas area was independently associated with 30-day...
In this prospective single-institution study, functional status trajectory one year after intervention was compared for transcatheter (TAVR) versus surgical aortic valve replacement (SAVR). A moderate/large decline compared to preintervention status...
Edwards Lifesciences announced that the SAPIEN 3 Ultra system has received US Food and Drug Administration approval for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are...
The authors, using the STS/ACC TVT Registry, analyzed the the occurrence of patient-prosthesis mismatch (PPM) in 62,215 patients enrolled between 2014 and 2017. They found that severe and moderate PPM...
This study analyzed the cost-effectiveness of TAVR versus SAVR in 3110 intermediate-risk aortic stenosis patients from the PARTNER-2 trial. Using a Markov model, the authors found that TAVR is economically...
Patient Care and General Interest Truly remote percutaneous coronary intervention was performed in five human patients at Apex Heart Institute in Ahmedabad, India. Virtual reality comes to continuing medical education,...


